Real-World Experience of Rapid Obinutuzumab Administration: Time to Change Obinutuzumab Infusion Rates

被引:0
|
作者
Cunningham, Joel [1 ]
Sparksman, David [1 ]
Gordon-Walker, Dominic [1 ]
Sarkies, Patrick [1 ]
De Silva, Ravindu [1 ]
Small, Matthew [1 ]
Collins, Angela [1 ]
Shah, Nimish [1 ]
机构
[1] Norfolk & Norwich Univ Hosp, Deparment Haematol, Norwich, Norfolk, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH22-PO59
引用
收藏
页码:107 / 107
页数:1
相关论文
共 50 条
  • [1] Adoption of rapid obinutuzumab infusions: real world experience
    Cunningham, J.
    Sparksman, D.
    Gordon-Walker, D.
    Collins, A.
    Shah, N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 100 - 100
  • [2] Real-World Analysis of Obinutuzumab-Based Immunochemotherapy in Follicular Lymphoma in Chinese Population
    Chen, Xi
    Xu, Jieyu
    Yu, Haifeng
    Lei, Tao
    Li, Cong
    Yang, Haiyan
    BLOOD, 2023, 142
  • [3] Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience
    Autore, Francesco
    Fresa, Alberto
    Innocenti, Idanna
    Tomasso, Annamaria
    Morelli, Francesca
    Corbingi, Andrea
    Sora, Federica
    Laurenti, Luca
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 641 - 643
  • [4] Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and Tolerability
    Tedeschi, Alessandra
    Galitzia, Andrea
    Frustaci, Annamaria
    Patti, Caterina
    Sanna, Alessandro
    Appio, Lorena
    Schiattone, Luana
    Sportoletti, Paolo
    Barate, Claudia
    Casadei, Beatrice
    Ferrarini, Isacco
    Figuera, Amalia
    Stelitano, Caterina
    Loseto, Giacomo
    Visentin, Andrea
    Coscia, Marta
    Moia, Riccardo
    Motta, Marina
    Russo, Filomena
    Tani, Monica
    Capochiani, Enrico
    Ferrari, Angela
    Gentile, Massimo
    Giacchetti, Roberta
    Giordano, Annamaria
    Innao, Vanessa
    Varettoni, Marzia
    Vozzella, Federico
    Cibien, Francesca
    Gottardi, Daniela
    Lista, Enrico
    Nocilli, Laura
    Pasquini, Cristina
    Vanazzi, Anna
    Santambrogio, Elisa
    Murru, Roberta
    Mauro, Francesca Romana
    Lucignano, Mariano
    Laurenti, Luca
    BLOOD, 2023, 142
  • [5] PURGING WITH CHLORAMBUCIL TO PREVENT INFUSION-RELATED REACTIONS BEFORE OBINUTUZUMAB ADMINISTRATION: A MONOCENTRIC PILOT EXPERIENCE.
    Fresa, A.
    Autore, F.
    Innocenti, I.
    Corbingi, A.
    Morelli, F.
    Tomasso, A.
    Laurenti, L.
    HAEMATOLOGICA, 2019, 104 : 103 - 103
  • [6] Real-world time to discontinuation of first-line venetoclax plus obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1227 - 1235
  • [7] Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction
    Takeshi Hara
    Ryohei Suzuki
    Akihisa Ohno
    Kengo Yamakawa
    Yasumasa Yamagishi
    Yoshihiro Sugiyama
    Takuya Sobajima
    Rie Yamada
    Rie Matsumoto
    Yoko Ikeda
    Masanori Murayama
    Hisashi Tsurumi
    International Journal of Hematology, 2020, 111 : 585 - 590
  • [8] Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction
    Hara, Takeshi
    Suzuki, Ryohei
    Ohno, Akihisa
    Yamakawa, Kengo
    Yamagishi, Yasumasa
    Sugiyama, Yoshihiro
    Sobajima, Takuya
    Yamada, Rie
    Matsumoto, Rie
    Ikeda, Yoko
    Murayama, Masanori
    Tsurumi, Hisashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 585 - 590
  • [9] Real-World Infusion Center Experience With Alemtuzumab in Canada
    Guerette, Christine
    Milot, Michelle
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 35 - 36
  • [10] Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Lei, Matthew M.
    Sorial, Mark N.
    Lou, Uvette
    Yu, Michelle
    Medrano, Andrea
    Ford, Josie
    Nemec, Ronald A.
    Abramson, Jeremy S.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 653 - 659